Compare NetEase Inc (NTES) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs Sana Biotechnology Inc — how do they compare? NetEase Inc trades at $134.95 (market cap $86.14B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: NetEase Inc is far larger — about 98.6× Sana Biotechnology Inc's market cap, and NetEase Inc pays a 2.25% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| NTES | SANA | |
|---|---|---|
Market Cap | $86.14B | $873.84M |
Sector | Media | Health |
52-Week High | $159.34 | $5.92 |
52-Week Low | $109.26 | $2.68 |
Enterprise Value | $62.61B | $848.03M |
Dividend Yield | 2.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
